Ras proteins are small GTP binding proteins that serve as critical relays in a variety of signal transduction pathways in eukaryotic cells. Like most metazoan Ras proteins, yeast Ras is post-translationally modified by addition of a farnesyl and a palmitoyl moiety, and these modifications are required for targeting the protein to the cytoplasmic face of the plasma membrane and for biological activity of the protein. We have constructed mutants of the yeast (Saccharomyces cerevisiae) Ras that are farnesylated in vivo but are not palmitoylated. These mutant proteins are not localized to the plasma membrane but function in the cell as well as the wild-type protein. Such mutants are viable but fail to induce a transient increase in intracellular cAMP concentration in response to glucose addition, although this deficiency does not yield a marked growth phenotype. These results are consistent with the hypothesis that the essential role of the farnesyl moiety on yeast Ras is to enhance productive interaction between Ras and its essential downstream target, adenylyl cyclase, rather than to localize Ras to the plasma membrane.
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All Ras proteins undergo a series of post-translational modifications of their carboxyl termini, including farnesylation and in most cases palmitoylation, that are required for partitioning the proteins to the cytoplasmic face of the plasma membrane (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . In metazoans, this localization appears to be essential for Ras's role in signal transduction, since signaling through the pathway relies on repartitioning the Ras activating protein, Sos, and the Ras effector protein, Raf, to the membrane compartment at which Ras resides as the means of completing the signaling circuit (11) (12) (13) (14) (15) (16) (17) .
Yeast Ras proteins participate in a signal transduction pathway that appears to connect glucose availability to the metabolic activity of the cell. The two Ras proteins, encoded by RASI and RAS2, stimulate adenylyl cyclase to yield increased cAMP levels, which in turn activates the cAMPdependent protein kinase (A kinase) (18, 19) . Phosphorylation of a number of target proteins by activated A kinase results in enhanced glycolysis, mobilization of energy reserves, and specific transcriptional activation. The precise biological signal that activates Ras is not known, but addition of glucose to starved cells yields a transient increase in cAMP levels that is dependent on Ras and on the Ras guanine nucleotide exchange factor, Cdc25p (20) (21) (22) (23) (24) .
Previous observations have established a correlation between post-translational processing of Ras, its membrane localization, and its biological activity. Like metazoan Ras proteins, yeast Ras proteins are post-translationally modified by farnesylation, palmitoylation, proteolytic removal of the terminal three amino acids, and carboxyl methylesterification (2, 6, 9) . Yeast Ras proteins are located predominantly in the cell in a membrane compartment, as are other components of the signal transduction pathway with which Ras interacts, including adenylyl cyclase and Cdc25p (M. Jacquet, personal communication; refs. 25 and 26) . Mutation of the site of farnesylation in Ras blocks all post-translational processing, abolishes its biological activity, and renders the protein predominantly cytoplasmic (27) . This has prompted models suggesting that post-translational modification of Ras is essential for its biological activity because it allows colocalization of Ras with other components of the signal transduction apparatus.
In this report we describe mutants of Ras in Saccharomyces cerevisiae that separate membrane localization from biological activity. We have found that mutations of the palmitoylation site of Ras block palmitoylation but not other post-translational processing steps. In (28) by cotransforming linear fragments containing the RAS2 allele (29) along with plasmid pHV1 (30) tTo whom reprint requests should be addressed.
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selecting His' transformants and screening them for Ura-. Allele replacement was confirmed by PCR analysis.
The 2 m,u plasmids YEp51 GAL10-RAS2 and YEp51
GAL10-RAS2C3l9s have been described (27 Immunofluorescence Analyses. Cells were grown to 107 cells per ml in synthetic complete medium lacking leucine and then fixed and prepared for immunofluorescence as described (33) . The primary anti-Ras2p monoclonal antibody, y-RAS2-3G6, was used as undiluted culture supernatant; the goat anti-mouse secondary antibody (Zymed) was conjugated with biotin and visualized with fluorescein isothiocyanate-conjugated streptavidin (Zymed) as described (34) . Images were obtained with a Bio-Rad MRC600 confocal imaging head, equipped with an ILT argon/krypton laser, mounted on a Nikon Optiphot II microscope using a 60X planapo objective (Nikon; numerical aperture, 1.40; oil immersion objective; zoom factor, 2). While optimal results for visualization of Ras protein localization were obtained with strains in which Ras protein was moderately overexpressed, identical results to those shown in Fig. 2 were obtained with RAS2 expressed under its own promoter on an intermediate-copy level plasmid, pUV2, and on a low-copy plasmid, pRS316. These constructs were also tested in a rasl ras2 strain with identical results.
Iodine Assay and Heat Shock Analysis. Strains were grown in YEPD plates and exposed to iodine vapors as described (18) . Heat shock analyses were performed by incubating YEPD plates with the relevant strains at 55°C for the indicated times and then shifting to 30°C for 24 hr (35 sylation is required for all subsequent modifications, precluded palmitoylation, cleavage, and methyl esterification as well (4) . The structures of the carboxyl termini of the wild-type Ras2p and the two mutant proteins are summarized in Table 1 . The inability of Ras2p(C318S) to undergo palmitoylation is documented in Fig. 1 . The absence of any modification of Ras2p(C319S) has been previously shown (27, 36, 37) .
We examined the subcellular localization ofwild-type Ras2p and the mutant Ras2p proteins by indirect immunofluorescence using confocal microscopy. As evident in Fig. 2 , wildtype Ras2p resides primarily on the plasma membrane. In contrast, Ras2p(C318S), which lacks only the palmitoyl moiety, and Ras2p(C319S), which lacks the palmitoyl and farnesyl groups, are localized predominantly to the cytoplasm, with no apparent enrichment in the plasma membrane. The patterns of staining of the two mutant proteins are indistinguishable. Identical results are obtained with strains carrying the RAS2 alleles on low-copy CENplasmids, indicating that <10% of the Ras2p(C318S) is localized to the plasma membrane (data not shown). Results from subcellular fractionation studies of the wild-type and mutant proteins are consistent with those obtained by immunofluorescence (data not shown). The requirement for membrane localization on palmitoylation is also observed with two other mutant proteins, Ras2(A308-317) and Ras2(A308-318). The former lacks the 10 amino acids immediately upstream from the palmitoylation site and exhibits a wild-type localization pattern; in contrast, the latter mutant lacks the same 10 amino acids as well as the palmitoylation site and shows no localization to the membrane (Fig.  2 Lower). Thus, membrane localization of Ras2p requires palmitoylation in addition to farnesylation; farnesylation alone is not sufficient to yield stable association of Ras2p with the plasma membrane. Similar results are observed for mammalian Ras proteins (38, 39) .
Ras Biological Activity Requires Farnesylation But Not
Palmitoylation. Despite the fact that Ras2 protein lacking the palmitoyl moiety alone and Ras2 protein lacking the palmitoyl and farnesyl moieties show identical subcellular localization, the biological activities of these two proteins are quite distinct. The first demonstration of the difference in function of the two mutant proteins is in cell viability. Wild-type yeast contain two RAS genes, RAS1 and RAS2, and require at least one functional RAS gene for mitotic growth (19) . As shown in Fig. 3 Upper, rasl RAS2C3l8s spores show normal viability, whereas rasl ras2C3l9s spores fail to yield colonies. Ras. Strains containing dominant mutations of RAS2, such as G19V, that lock the protein in its activated state exhibit a variety of distinct phenotypes. These include diminished accumulation of glycogen, as monitored by staining colonies with iodine vapors, and increased sensitivity to heat shock (18, 35) .
Second site mutations introduced into the RAS2G19V gene that diminish the function of the protein attenuate these activated phenotypes. Thus, the degree to which a mutation inserted into RAS2G19V gene reverses the activated phenotype of strains carrying it is a measure of the degree to which that mutation abolishes the biological activity of the Ras2 protein. As shown in Fig. 4 Upper, RAS2G19V strains and RAS2G19V,C318S strains show the same diminished level of iodine strains, compared to RAS2 strains. In contrast, RAS2G19VC3195 strains show the same intense level of staining as do ras2 strains. Thus, by this assay the C318S mutation maintains full biological activity, whereas the C319S mutation completely abolishes activity. A similar situation is observed with heat shock: the RAS2G19V,c318s strain exhibits heat shock sensitivity similar to that of the RAS2G19V strains, whereas the p4S2G19VC319S strain behaves like a ras2 strain. In this assay, though, the RAS2G19V,C318S strain is slightly more resistant than the RAS2Gl9V strains, suggesting that the C318S mutation is not completely innocuous. Nonetheless, these results substantiate the conclusions from the previous assays that the C319S mutation severely compromises the function of the Ras2 protein whereas the C318S mutation has only a minor effect.
Palmitoylation severely compromised for glucose-induced transient activation of adenylyl cyclase. As has been previously reported and as shown in Fig. 5 , addition of glucose to a rasl RAS2 strain yields a rapid but transient increase in the intracellular concentration of cAMP (20) (21) (22) 40) . In contrast, addition of glucose to a rasl RAS2C318S strain yields absolutely no transient increase in cAMP accumulation. Thus, loss of Ras2p palmitoylation prevents rapid activation of adenylyl cyclase to external stimuli, presumably as a consequence of diminished membrane localization of Ras2p. However, this deficiency does not yield a substantive cellular phenotype.
DISCUSSION
Our results have shown that farnesylation of Ras protein, but not its membrane targeting, is required for Ras to fulfill its essential function in the cell-that is, regardless of the subcellular location of Ras, productive interaction between Ras and one or more of the components of the Ras signal transduction pathway is dependent on the farnesyl moiety. In its essential role in yeast, Ras serves as a substrate for Cdc25p, a guanine nucleotide exchange factor, and stimulates adenylyl cyclase, the single essential effector target of Ras in the cell (18, 24, 41) . In vitro analysis suggests that Cdc25p-catalyzed exchange of guanine nucleotide is not affected by the presence of the farnesyl residue on Ras (42) . However, Kuroda et at (43) have shown that farnesylated Ras2p had a significantly higher kinetic affinity for adenylyl cyclase in vitro than did unmodified Ras2p. Our results are consistent with the hypothesis that the farnesyl group plays a direct role in the interaction between Ras2p and adenylyl cyclase and documents that this role of the farnesyl residue is critical for the biological activity of Ras in vivo.
We have previously shown that, although a single copy of ras2C3l9s does not impart essential RAS function to the cell, rasl ras2 strains carrying multiple copies ofras2C3l9s are viable. Thus, overexpression of Ras2p (C319S) (45) showed that the farnesyl moiety could be replaced by a different membrane targeting signal-myristoylation of the amino terminus-to yield a protein with normal or nearnormal activity. Thus, farnesylation per se is not required for Ras function in mammalian cells. More recently, Hancock et at (38) showed that elimination of the palmitoylation site of Ha-ras or the carboxyl polybasic region of Ki-ras caused loss of membrane localization. However, in this case the mislocalized protein retained transformation potential and the ability to mediate activation of mitogen-activated protein kinase, as long as the Ras protein was farnesylated (39) . Thus, the mammalian Ras protein requires either farnesylation or membrane localization for biological activity.
Alternatively, as we suggest for yeast Ras, farnesylation may play a critical role in promoting protein-protein interaction of mammalian Ras, for which some evidence exists (10, 42, 43, 46) , but the myristoyl moiety may effectively substitute for farnesyl in this capacity. If this is the case, then the role of post-translational modification in Ras-mediated signal transduction may prove to be the same in yeast and mammals.
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